Advertisement
Australia markets close in 1 hour 58 minutes
  • ALL ORDS

    8,013.90
    +50.80 (+0.64%)
     
  • ASX 200

    7,761.80
    +46.30 (+0.60%)
     
  • AUD/USD

    0.6653
    -0.0012 (-0.19%)
     
  • OIL

    78.24
    -0.26 (-0.33%)
     
  • GOLD

    2,329.90
    -24.90 (-1.06%)
     
  • Bitcoin AUD

    101,554.98
    +130.95 (+0.13%)
     
  • CMC Crypto 200

    1,431.22
    +36.18 (+2.59%)
     
  • AUD/EUR

    0.6155
    -0.0003 (-0.06%)
     
  • AUD/NZD

    1.0772
    +0.0003 (+0.02%)
     
  • NZX 50

    11,806.37
    +64.49 (+0.55%)
     
  • NASDAQ

    19,465.18
    +254.99 (+1.33%)
     
  • FTSE

    8,215.48
    +67.67 (+0.83%)
     
  • Dow Jones

    38,712.21
    -35.21 (-0.09%)
     
  • DAX

    18,630.86
    +260.92 (+1.42%)
     
  • Hang Seng

    18,031.89
    +94.05 (+0.52%)
     
  • NIKKEI 225

    38,855.12
    -21.59 (-0.06%)
     

Inspire Medical Systems (NYSE:INSP) shareholders have earned a 57% CAGR over the last five years

Long term investing can be life changing when you buy and hold the truly great businesses. While the best companies are hard to find, but they can generate massive returns over long periods. For example, the Inspire Medical Systems, Inc. (NYSE:INSP) share price is up a whopping 847% in the last half decade, a handsome return for long term holders. And this is just one example of the epic gains achieved by some long term investors. On top of that, the share price is up 13% in about a quarter. We love happy stories like this one. The company should be really proud of that performance!

With that in mind, it's worth seeing if the company's underlying fundamentals have been the driver of long term performance, or if there are some discrepancies.

View our latest analysis for Inspire Medical Systems

Because Inspire Medical Systems made a loss in the last twelve months, we think the market is probably more focussed on revenue and revenue growth, at least for now. Shareholders of unprofitable companies usually expect strong revenue growth. Some companies are willing to postpone profitability to grow revenue faster, but in that case one does expect good top-line growth.

ADVERTISEMENT

In the last 5 years Inspire Medical Systems saw its revenue grow at 48% per year. That's well above most pre-profit companies. Arguably, this is well and truly reflected in the strong share price gain of 57%(per year) over the same period. It's never too late to start following a top notch stock like Inspire Medical Systems, since some long term winners go on winning for decades. On the face of it, this looks lke a good opportunity, although we note sentiment seems very positive already.

You can see below how earnings and revenue have changed over time (discover the exact values by clicking on the image).

earnings-and-revenue-growth
earnings-and-revenue-growth

Inspire Medical Systems is well known by investors, and plenty of clever analysts have tried to predict the future profit levels. So it makes a lot of sense to check out what analysts think Inspire Medical Systems will earn in the future (free analyst consensus estimates)

A Different Perspective

We're pleased to report that Inspire Medical Systems shareholders have received a total shareholder return of 68% over one year. Since the one-year TSR is better than the five-year TSR (the latter coming in at 57% per year), it would seem that the stock's performance has improved in recent times. In the best case scenario, this may hint at some real business momentum, implying that now could be a great time to delve deeper. I find it very interesting to look at share price over the long term as a proxy for business performance. But to truly gain insight, we need to consider other information, too. Even so, be aware that Inspire Medical Systems is showing 1 warning sign in our investment analysis , you should know about...

For those who like to find winning investments this free list of growing companies with recent insider purchasing, could be just the ticket.

Please note, the market returns quoted in this article reflect the market weighted average returns of stocks that currently trade on American exchanges.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Join A Paid User Research Session
You’ll receive a US$30 Amazon Gift card for 1 hour of your time while helping us build better investing tools for the individual investors like yourself. Sign up here